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 Environmental enrichment, i.e., increased intellectual, social, and physical activity
makes brain more resilient to subsequent neurological disease. The mechanisms for this
effect remain incompletely defined, but evidence shows tumor necrosis factor-alpha (TNF-
α) is involved. TNF-α, at acutely high levels, possesses the intrinsic capacity to enhance
injury associated with neurological disease. Conversely, the effect of TNF-α at low-levels is
nutritive over time, consistent with physiological conditioning hormesis. Evidence shows
that neural activity triggers low-level pro-inflammatory signaling involving TNF-α. This
low-level TNF-α signaling alters gene expression, resulting in an enhanced resilience to
disease. Brain-immune signaling may become maladaptive when increased activity is
chronic without sufficient periods of reduced activity necessary for nutritive adaptation.
Such tonically increased activity may explain, for example, the transformation of episodic
to chronic migraine with related increased susceptibility to spreading depression, the most
likely underlying cause of this malady. Thus, TNF-α, whose function is to alter gene expres-
sion, and its principal cellular source, microglia, seem powerfully positioned to orches-
trate hormetic immune signaling that establishes the phenotype of neurological health
and disease from brain activity. 
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INTRODUCTION
Brain is unique among organ structures in that it exists to predict
(Llinás 2002), a capacity that requires constant “reprogramming.”
Importantly, reprogramming increases the brain’s resistance to neurolog-
ical disease. Neural reprogramming is classically evidenced by Hebbian
synaptic plasticity, and extends to environmental enrichment (EE; i.e.,
increased intellectual, social, and physical activity), which is well-known to
be protective (for review see van Praag et al. 2000; Will et al. 2004). 
Reprogramming is also an inherent capacity of the immune system
(Waldmann 2002; Graca and Waldmann 2006; Waldmann et al. 2008). In
addition, immune system reprogramming may be a well-conserved
process by which ischemic preconditioning stimuli applied to brain prompt
subsequent neuroprotection (Marsh et. al. 2009). 
Our focus is to illustrate how immune stimuli within brain, associated
with neural activity, similarly reprogram gene function to create the phe-
notype of increased neurological health through interactive signaling
between neurons and glia. Increasing evidence indicates that neural and
immune systems interact in response to increased activity to establish the
phenotype of enhanced brain health. This activity-dependent cooperative
reprogramming may be driven by tumor necrosis factor-alpha (TNF-α),
an innate immunity cytokine that emanates from microglia under normal
circumstances (Hulse et al. 2008). 
Classically, microglia, principal immune signaling cells within brain,
have been recognized for their powerful destructive capacities to
enhance brain injury via mechanisms that include increased expression
of TNF-α (Chao and Hu 1994; Dawson et al. 1996; Barone et al. 1997;
Meistrell et al. 1997; Aggarwal et al. 2001; Zou and Crews 2005).
Accordingly, why would the brain use lethal signaling systems to enhance
its strength? Developing evidence indicates the answer lies in the old say-
ing “…what doesn’t kill you makes you stronger …” (Hadley 2003). This
notion termed “physiological conditioning hormesis” (Calabrese et al.
2007) is increasingly recognized as a well-conserved capacity of biological
systems, including brain (Mattson et al. 2002; Mattson 2008a, 2008b).
Mounting evidence indicates that TNF-α and microglia can be neuropro-
tective (Cheng et al. 1994; Wilde et al. 2000; Hallenbeck 2002; Stoll et al.
2002; Streit 2005, 2006; Turrin and Rivest 2006; Carson et al. 2007;
Hanisch and Kettenmann 2007; Sriram and O’Callaghan 2007; Hulse, et
al. 2008; Salmina 2009). 
Hormesis is a dose-response pattern involving low-level stimulation
and high-level inhibition (Calabrese and Baldwin 2003). Hormesis is seen
with neuroprotective treatments for stroke and brain trauma (Calabrese
2008) and also may play a role in the brain’s intrinsic capacity to protect
itself against injury. Importantly, such irritative signaling that initiates
neuroprotection requires time to develop. 
R. P. Kraig and others
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We present original data and related literature to support and extend
the suggestion that brain uses TNF-α-dependent signaling (Arumugam et
al. 2006) from microglia to initiate subsequent adaptive changes that pro-
vide the neuroprotection consistent with physiological conditioning
hormesis (Calabrese et al. 2007). Furthermore, we propose that this nutri-
tive scenario may become maladaptive if initiating stimuli (i.e., neural
activity) rise to a frequency that precludes sufficient recovery periods
needed for adequate adaptive responses. We suggest the latter may exem-
plify the transformation of episodic to chronic migraine with related
increased susceptibility to spreading depression, the most likely underly-
ing cause for this headache disorder (Lauritzen and Kraig 2005). Similar
considerations are likely to apply to other neurodegenerative disorders,
including temporal lobe epilepsy. 
ADAPTIVE POTENTIAL OF ENHANCED BRAIN ACTIVITY
Rationale for study of environmental enrichment-based neuroprotection
The mechanisms of endogenous neuroprotection are commonly
studied in reference to “ischemic tolerance,” a phenomenon where a
lethal stimulus brought below threshold imparts neuroprotection against
subsequent injury (Kirino 2002; Dirnagl et al. 2003, Dirnagl et al. 2009).
As noted above, such neuroprotection most often includes the study of
stimuli applied to brain. Deciphering the means by which biologically
driven mechanisms mitigate brain injury will lead to improved treatment
strategies that may result in fewer negative sequelae and greater physio-
logical effects (Kraig and Kunkler 2002). The notion that treatments
should follow naturally evolved pathways has considerable merit. Our
interest in defining the mechanisms of EE-based neuroprotection
extends beyond traditional ischemic tolerance studies. This emphasis has
two distinct advantages. First, defining mechanisms will provide impor-
tant insights for new acute treatment strategies derived from stimuli with
no potential for confounding effects associated with lethal stimuli.
Second, detailed knowledge of underlying EE mechanisms will establish
the physiological bases (and therefore rationale) for neurological preven-
tative health strategies designed to lessen the impact of neurological dis-
eases. The latter would empower patients and healthcare providers with
evidence-based strategies to improve their health before the onset of
brain disease. 
Clinical evidence for the environmental enrichment benefits
Considerable clinical evidence indicates that moderately increased
exercise lessens the severity of neurodegenerative disease. For example,
Chen and coworkers (2005) noted that higher levels of physical activity
may lower the risk of Parkinson’s disease development in men prone to
TNF-α and microglial hormesis from brain activity
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develop this disorder. Curiously, women in the study showed no benefit.
Rovio and coworkers (2005) also noted that physical activity at midlife
correlated with decreased risk of dementia and development of
Alzheimer’s disease in later life. Van Gelder and coworkers reported a
similar positive impact of physical activity begun later in life (2004). 
Importantly to our thesis, Rovio and colleagues (2005) observed the
greatest reduction in disease development, due to increased physical
activity, in individuals with a genetic marker for Alzheimer’s disease,
APOE4. This finding begins to illustrate the concepts put forward by
Silverman (2004) in a recent article entitled, “Rethinking Genetic
Determinism.” Silverman notes inadequacies of the traditional assump-
tions that “…the gene is deterministic in gene expression and can there-
fore predict disease propensities.” He suggests instead that more atten-
tion should be given to how “environment” alters genetic propensity to
influence phenotype. While genetic determinism may be valid in specific
circumstances (e.g., lethal genetic changes), our research focus is greatly
influenced by the therapeutic potential of Silverman’s suggestion, which
we believe EE-based neuroprotection powerfully exemplifies. 
A second caveat of EE-based neuroprotection is whether physical
activity alone is sufficient to induce the protection. For example, exercise
is sufficient to retard development of cardiovascular disease (Thompson
et al. 2003). However, physical activity alone may not be adequate for neu-
roprotection from EE (Sturman et al. 2005). Instead, learning (van Praag
et al. 2000) may be the key component by which EE (i.e., increased intel-
lectual, physical, and social activity) triggers neuroprotection. 
Experimental evidence for environmental enrichment neuroprotection
Evidence from experimental animal studies supports the neuropro-
tective capacity of EE (Will et al. 2004). EE initiated after brain trauma
(Wagner et al. 2002) or stroke (Dahlqvist et al. 2004) enhances cognitive
function involving the hippocampus when compared to non-enriched
animals. EE also slows cognitive decline in ageing rodents (Kempermann
et al. 2002). 
EE is also effective in enhancing brain function after injury to devel-
oping brain. Early enrichment in perinatal rats a day after
hypoxia/ischemia results in partial recovery of memory deficits (Pereira
et al. 2008). However, this effect was only seen in females. A common
problem in studies of EE is so-called dominant male effect that stresses
other enriched male animals (see below). This prompted many to
include only females in enrichment studies. Alternatively, when EE starts
two weeks after neonatal ischemia, male rats show significant improve-
ment compared to non-enriched counterparts (Pereira et al. 2007).
Furthermore, postnatal EE can ameliorate behavioral effects of fetal alco-
hol syndrome (Hannigan et al. 2007) and the consequences of other neu-
R. P. Kraig and others
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rological disease models (Nithianantharajah and Hannan 2006).
Accordingly, EE and experiential interventions may reduce or ameliorate
the neuronal and non-neuronal abnormalities caused by injury to the
developing brain (Dong and Greenough 2004). Remarkably, the positive
effects of EE are seen when EE is initiated long after perinatal injury (i.e.,
after weaning). 
EE is also effective when initiated before the onset of neurological dis-
ease. For example, EE reduces temporal lobe seizures in adult rats and
reduces cognitive deficits compared to non-enriched counterparts
(Young et al. 1999). 
Our studies using in vivo and in vitro models of excitotoxic hip-
pocampal injury confirm and extend the evidence that learning from EE
is neuroprotective. First, we did not observe any clinical evidence of a
dominant male effect with our enrichment cage conditions (Figure 1),
perhaps because the cage was sufficiently large (Marashi et al. 2003). This
TNF-α and microglial hormesis from brain activity
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FIGURE 1. Mouse environmental enrichment cage. Groups of seven mice were housed as shown in
an environmental enrichment (EE) cage. This consisted of a cage with a microisolator filter top (A),
free access to food and water (B), and an array of toys, running wheel and socialization bowl (C) that
allowed increased intellectual, physical and social volitional opportunities. The tunnels (120 cm in
length) were changed weekly to a new configuration along with all cage materials. The EE cage size
was 60x56x21 cm while the non-enriched (NE) cage, which only contained the microisolator filter
top and bedding, was 28x17x13 cm. Animals were housed for 28 days under EE or NE conditions
before analyses. Wood chips for chewing were discarded after each experiment and the EE equip-
ment was cleaned by hand-scrubbing with chlorine dioxide (Clydox®) every week while the cages
were cleaned by standard automated procedures. Room temperature was controlled to 22 °C with the
light-dark cycle beginning at 6 AM and ending at 6 PM. This housing configuration showed no evi-
dence of a dominant male. The cages were manufactured by Ancare.
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conclusion is further supported by the fact that we did not find any out-
lying serum corticosterone values within animal groups (see below).
Second, 28-day exposure to EE triggered a significant increase in hip-
pocampal (i.e., contextual) learning compared to non-enriched counter-
parts (Figure 2). Third, this EE paradigm significantly reduced CA3 area
hippocampal pyramidal neuron loss from kainic acid-induced temporal
R. P. Kraig and others
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FIGURE 2. Environmental enrichment increased contextual learning. Emotional memory was exam-
ined (n=12 animals/group) by using a fear-conditioning task after 28-day exposure to an enriched
environment (EE) or non-enriched environment (NE). NE and EE mice showed immediate freezing
response levels (17±3 v. 24±2 %) that were not significantly different, indicating that responses to the
unconditioned stimulus of the shock were the same between NE and EE mice. However, when com-
pared to NE mice, the contextual freezing responses in the EE mice (29±3 v. 40±4 %) were signifi-
cantly (“*”, P > 0.05, Student’s t test) higher, indicating that contextual conditioning memory, a
reflection of hippocampal function, was significantly enhanced by EE. Results here and elsewhere are
listed as mean ± standard error of mean. 
[A fear-conditioning task was used to evaluate the hippocampal-dependent emotional memory in the mice as pre-
viously described by Tang and coworkers (1999). Briefly, the apparatus consisted of a shock chamber (25x25x37.5
cm), a multi-tone producer and a speaker, an electrical-shock producer, a photobeam-scanner, and a computerized
workstation from TruScan multi-parameter activity monitor system (Coulboun Instruments). The floor of the
chamber consisted of 24-bar inescapable shock grids. The walls of the chamber were transparent so that the behav-
ioral responses in the chamber could be automatically recorded with the photobeam-scanner and at the same time
recorded by a video camera or experimenters. One day before training, animals were individually habituated to the
chamber three times for five min each time. The conditioned stimulus (CS) used for training was an 85 dB sound
at 2,800 Hz, and the unconditioned stimulus (US) was a continuous scramble shock at 0.75 mA. During train-
ing, mice were individually put into the chamber and allowed to explore for three min before being exposed to the
CS for 30 sec. During the last two sec of the CS, the US was delivered to the mouse through the grids for 2 sec. After
this CS/US pairing, mice were allowed to stay in the chamber for another 30 sec for an enhancement of the asso-
ciation with the special context (chamber, grids, and cues around the chamber). Mice were then immediately
returned to their original cages. Throughout the procedures, freezing responses were recorded with a five sec inter-
val sampling method. Freezing responses were judged as complete immobility of any part of the body, except for res-
piratory movements. Freezing responses during the 30 sec period after shock were recorded as immediate freezing.
Retention tests were carried out 24 hr after the training sessions. During the retention test, each mouse was placed
back into the same chamber for contextual freezing measurement and freezing responses were recorded for five min.
The floor of the chamber was cleaned with 75% ethanol between tests. At least five min elapsed before the cham-
ber was reused. Throughout all the experiments, the experimenters were blind to the treatment condition. Mice
(C57BL/10J) were from Charles River (four-six months old) and both female and male mice were mixed in all
experiments.]
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lobe epilepsy, and significantly improved animal survival compared to
non-enriched counterparts (Figure 3). 
Initially, serum corticosterone levels were measured to probe for
potential stress reaction from exposure to EE. Our results indicate what
may be an important signaling pattern associated with increased learning
from EE. We, like others (Kempermann et al. 2002), found that morning
TNF-α and microglial hormesis from brain activity
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FIGURE 3. Environmental enrichment protected hippocampus against excitotoxic injury. A well-
established model of temporal lobe epilepsy (TLE) was used to determine whether an enriched envi-
ronment (EE) evoked hippocampal neuroprotection compared to a non-enriched environment
(NE). (A) Representative Fluoro-Jade images show caudal CA3 area hippocampal pyramidal neuron
death (arrow) four days after kainic acid injections in NE compared to EE mice. (B) Quantification
of neurons lost (n=5/group; white) as well as number of surviving animals (n=28/group; gray)
showed that EE triggered a significant (“*”, P < 0.05, Student’s t test) reduction in the number of neu-
rons lost and a significant (P<0.01) increase in the percentage of surviving animals. Specific values
were 117±17 v. 23±16 neurons lost and 45±8 v. 77±6 % surviving mice (Kraig et al. 2004). 
[TLE was induced by a subcutaneous injection of freshly prepared kainic acid (30 mg/kg (Calbiochem) dissolved
in phosphate buffered saline (PBS; at 1mg/mL; Avanzini et al. 1998)) in C57BL/10J mice. Sham controls
received similar volume subcutaneous injections of PBS. Animals were briefly restrained in a holding device for
injections. After injections, animals were placed in individual cages without lids for continuous observation.
Seizure severity was quantitated (every 20 min during continuous monitoring) for the next four hrs according to
a scale proposed by Racine (1972) and modified to include death (Hulse et al. 2004). This rating was used to
ensure that all animals included for study reached the same general level of seizure severity. Those that did not
were excluded from study. In the event that mice experienced continuous seizures for 20 min, they would have been
euthanized. No animals had to be removed or euthanized in this study. At the conclusion of observation periods,
animals were kept in individual cages with standard housing until their brains were serially sectioned (40 µm)
through the hippocampus. TLE injury was measured using Fluoro-Jade staining (Schmued and Hopkins 2000)
to count dying neurons using stereological techniques (Howard and Reed 1998; West 1999) for the CA3 area of
hippocampus (from sections taken every 240 µm).] 
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corticosterone levels from EE animals were modestly elevated compared
to non-enriched counterparts (Figure 4). However, we also found that
evening levels were significantly higher in EE animals compared to non-
enriched mice with nearly two-fold increase in circadian rhythm change
(Figure 4). A similar effect of EE on circadian corticosterone was report-
ed by others studying growing pigs (de Jong et al. 2000). 
Phasically elevated corticosterone can initially enhance hippocampal
function, whereas chronically elevated corticosterone inhibits hippocam-
pal function (de Kloet et al. 1999; Zoladz and Diamond 2008). Diamond
and coworkers showed that corticosterone enhances primed burst elec-
trical potentiation of hippocampal pyramidal neurons (Diamond et al.
1992; Kim and Diamond 2002). Moderate and intermittent corticos-
terone levels enhance electrical activity, while extreme and chronically
elevated levels (e.g., consistent with clinical depression) inhibit electrical
responses. These effects are consistent with physiological hormesis. 
While corticosterone is a peripheral, and potentially systems-wide,
modulator of EE-based neuroprotection, our research focuses to intrinsic
brain signaling. There, TNF-α, and the cellular source of this innate
cytokine, microglia, are likely key mediators of EE-based neuroprotec-
R. P. Kraig and others
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FIGURE 4. Environmental enrichment and enhanced circadian corticosterone changes.
Measurement of mouse (C57BL/10J) serum circadian corticosterone levels 28 days after housing in
an enriched environment (EE) v. a non-enriched environment (NE) add further support to the sug-
gestion that low-level phasic stress (or irritative signaling) is associated with enhanced brain function.
For example, mice (n=14/group) housed in an NE showed AM-PM serum corticosterone levels of
14±2 and 70±9 ng/mL, and mice housed in an EE showed AM-PM levels of 18±3 and 122±18 ng/mL.
While AM levels were not significantly different between housing types, PM levels were significantly
different (“*”, P<0.001, Student’s t test) between housing types and significantly different (P=0.01)
from AM levels within housing types. (Kraig et al. 2004). 
[Serum was harvested following methods described by Hulse and coworkers (2004) to minimize acute stress and
control for circadian variations in samples. Briefly, anesthesia was induced within cages using a 10% halothane
(90% air). Animals were then quickly transferred to a new chamber with 3% halothane (97% air) until har-
vest, followed by rapid decapitation and collection of truncal blood for animals within a cage. Collections were per-
formed at 10 AM and 10 PM. Serum corticosterone measurements were performed by Diagnostic Systems
Laboratories (Texas).] 
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tion. This focus stems from data indicating that learning from EE initiates
neuroprotective and hormetic TNF-α signaling from microglia. 
First, EE (i.e., increased neural activity) triggered a significant
increase in expression of TNF-α within hippocampus, the site of excito-
toxic neuroprotection (Figure 5). Prior evidence shows that brain TNF-α
rises in response to treadmill activity (Ding et al. 2005). 
Second, TNF-α modulates synaptic activity. Within minutes of expo-
sure, TNF-α enhances synaptic efficacy by increasing the exocytosis of
AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid) recep-
tors in cultured neurons (Beattie et al. 2002) as well as the endocytosis of
inhibitory GABAA (γ-amino butyric acid type A) receptors (Stellwagen et
al. 2005). TNF-α also triggers increased expression of AMPA receptors as
a synaptic scaling response to activity deprivation by tetrodotoxin
(Stellwagen and Malenka 2006). Increased AMPA receptor expression is
seen with long-term potentiation (LTP) (Park et al. 2004), a well-accept-
TNF-α and microglial hormesis from brain activity
397
FIGURE 5. Environmental enrichment triggered hippocampal TNF-α expression. Increasing evi-
dence shows that brain may employ immune signaling to effect physiological conditioning hormesis
of environmental enrichment (EE) from increased “thinking.” For example, the innate cytokine
TNF-α, which can be lethal when associated with disease, may be a principal signal that initiates neu-
roprotection from EE. TNF-α is one of a group of innate immune cytokines that are highly interac-
tive with one another and can variably stimulate and/or inhibit each other’s expression. Accordingly,
multiplexed measurements of innate cytokines from hippocampus after non-enriched (NE) or EE
housing were completed. Notably, only TNF-α showed a significant (“*”, P<0.02, Student’s t test)
change from 404±12 to 488±22 pg/mg brain (n=6/group). A principal function of TNF-α is to alter
gene expression. Additionally brain TNF-α expression is activity-dependent. Therefore, enhanced
neural activity from EE may alter brain gene expression to create the phenotype of neuroprotection
via TNF-α. We tested for this possibility in the experiments of Figure 6. 
[Cytokine measurements were performed as previously described (Hulse et al. 2004; Kunkler et al. 2004) using
microsphere flow cytometric assays (Bio-Rad) run on a Bio-Plex analyzer with associated software. After 28 days
of NE or EE housing, mouse (C57BL/10J) hippocampi were harvested via group anesthesia as described in Figure
4 and detailed elsewhere (Hulse et al. 2004). While hippocampal TNF-α measurements showed a significant
change as described above, no significant changes were seen between NE and EE mice (n=6/group) for IL-1α
(34±2 v. 37±1), IL-1β (34±3 v. 39±1), IL-2 (77± v. 78±3), IL-4 (none detected), IL-6 (66±4 v. 64±4), IL-10
(10±1 v. 10±1), IFN-γ (none detected), and GM-CSF (none detected) (Kraig et al. 2003).] 
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FIGURE 6. Neuroprotection from long-term potentiation depends on TNF-α. Long-term potentia-
tion (LTP), a cellular model of learning, can be elicited in vitro using electrical or chemical stimula-
tion of susceptible brain regions. Chemical LTP (cLTP) maximizes the number of synapses and adja-
cent cells activated to undergo these plasticity changes. Accordingly, cLTP was used to show that phys-
iologically increased neural activity triggered neuroprotection from excitotoxic injury like that seen
in vivo and, importantly, the protection depended on TNF-α. (A) Specifically, NMDA irreversible
injury of CA1 in rat hippocampal slice cultures is significantly (“*”, P<0.001, ANOVA using Holm-
Sidak post hoc testing) reduced from control (normalized to 1.00±0.05, n=9) compared to cLTP
(0.59±0.02, n=6). Furthermore, chemical long-term depression (cLTD), a method that mimics elec-
trically induced reduction in synaptic efficacy, has no protective effect with a relative injury level of
0.95±0.05 (n=5). (B) Similarly, excitotoxic injury of the CA1 area produced by oxygen glucose dep-
rivation (OGD) is significantly (P<0.001) reduced to 0.53±0.05 (n=6) by cLTP compared to control
Figure 6 legend continued on next page
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ed cellular model of learning, and EE (Naka et al. 2005). While TNF-α
may not be necessary for LTP induction (Albensi and Mattson 2000) and
may retard it (Cunningham et al. 1996), TNF-α does play a role in relat-
ed homeostatic plasticity changes (Kaneko et al. 2008). This non-Hebbian
capacity of neurons (and neural tissue) to modulate their overall sensi-
tivity to activity may play a critical role in maintaining network stability
during development and in the mature, learning brain (Turrigiano et al.
1998; Goldberg et al. 2002). 
Recent work from Wheeler and coworkers (2009) shows that acute
exposure to TNF-α also leads to prompt increased neuronal excitability
that involves NMDA (N-methyl-d-aspartate) receptor expression.
Importantly, these workers studied in detail the molecular events that lead
to fusion of NMDA containing vesicles with the plasma membrane. Their
work demonstrates that TNF-α-induced activation of neutral sphingomyeli-
nase-2 and increased expression of ceramide are essential for increased sur-
face membrane expression of NMDA receptors and increased synaptic effi-
cacy. This is an important step forward for defining the signaling syntax by
which TNF-α from glia can acutely alter neuronal excitability. 
Third, neuroprotection from increased neuronal activity involves
TNF-α. Reduced synaptic efficacy from long-term depression has no
impact on CA1 area excitotoxic injury in hippocampal slices. On the
other hand, increased synaptic efficacy from LTP triggers a significant
reduction in injury that requires TNF-α (Kraig et al. 2006) (Figure 6). A
similar neuroprotective effect requiring TNF-α is seen with spreading
depression (Kraig et al. 2005). Spreading depression is non-injurious and
has many cellular and molecular features similar to learning and memo-
ry (Kraig and Kunkler 2002; Kunkler et al. 2005), including transient ele-
vation of TNF-α (Kunkler et al. 2004). Finally, Lambertsen and coworkers
(2009) used traditional knockout animals for TNF-α (and its cognate
receptors) to show that stroke injury and behavioral deficits are increased
in the absence of TNF-α signaling. Potentially confounding adaptive
effects may obscure observations using traditional knockout/in animals
(Gao et al. 1999); however, here TNF-α related adaptive changes may
account for the observations. 
Figure 6 legend, continued
(1.00±0.06; n=9). (C) Furthermore, neuroprotection from cLTP is significantly returned toward con-
trol levels of injury due to abrogation of TNF-α signaling using soluble TNF receptor 1 (sTNFR1).
Specific injury levels (n=5-6/group) were 1.00±0.06 for control, 0.51±0.05 for cLTP and 0.77±0.05 for
cLTP plus sTNFR1. Taken together, these experiments provide direct support for the suggestion that
low-level elevation in TNF-α from EE initiates activity-dependent neuroprotection. 
[cLTP was induced by 12 min exposure to a magnesium-free Ringer’s solution (37 °C) that contained 100 nM
Rolipram and 50 µM forskolin (Otmakhov et al. 2004). cLTD was evoked by 20 min exposure to Ringer’s solu-
tion containing 100 µM of RS-3,5-dihydroxyphenyl-glycine at 37 °C (Volk et al. 2006). sTNFR1 (200 ng/mL)
was applied to cultures 30 min before cLTP and after cLTP induction but was excluded from maximal injury
aspects of the excitotoxicity paradigms which followed previous descriptions (Hulse et al. 2008).] 
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FIGURE 7. Monomeric immunoglobin G may link neuronal activity to TNF-α expression.
Monomeric immunoglobin G (IgG) is not known to have signaling function in normal brain.
Instead, monomeric IgG triggers physiological hormetic signaling involving microglia that includes
increased recycling endocytosis and TNF-α secretion. Over time, these activating microglial changes
are associated with neuroprotection at physiological but not elevated levels of IgG. E-prostanoid
receptor subtype 2 activation (EP2A), used as an exemplary paracrine signal proportionate to hip-
pocampal pyramidal neuron activity, amplifies IgG-mediated effects on microglia. The following data
illustrate these conclusions. (A) Immunostaining with NeuN shows the principal neuron cytoarchi-
tecture for the pyramidal and dentate areas. Calibration bar is 250 µm. (B-D) Excitotoxic injury from
NMDA, using a fluorescent marker for cell death, was quantified in the CA1 area (dotted lines) and
expressed as a ratio in injury (B) over maximal injury (C) relative to control conditions (D). (E)
Exposure to IgG evokes significant (“*”, P<0.001) neuroprotection against NMDA injury, with ~20
µg/mL as the level expected for mammalian brain interstitial fluid under normal conditions.
Figure 7 legend continued on next page
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Fourth, monomeric immunoglobin G (IgG) may help interlink neu-
ronal activity to TNF-α production (Hulse et al. 2008) (Figure 7). EE acti-
vates microglia to a pro-inflammatory state (Ziv et al. 2006). While all
brain cell types plus adjacent endothelial cells are capable of releasing
TNF-α, microglia are recognized as the likely predominant source of this
pro-inflammatory cytokine, especially in response to disease (Hopkins
and Rothwell, 1995; Allan and Rothwell, 2001). Microglia are also likely
the predominant, if not sole, source of TNF-α under physiological condi-
tions including EE (Hulse et al. 2008). Monomeric IgG is commonly
regarded as a quiescent signaling molecule poised only to initiate poten-
tially injurious inflammatory reactions in response to disease via immune
complex formation and associated phagocytosis and TNF-α production.
Instead, IgG signaling within non-injured brain results in neuroprotec-
tion when it follows a physiological conditioning hormesis dose-response
pattern and takes time to develop. This IgG-mediated neuroprotection
involves enhanced microglial recycling endocytosis and TNF-α produc-
tion—changes that are quickly evident after IgG exposure. Importantly,
minocycline, known for its anti-inflammatory and neuroprotective effects
when administered after the onset of brain disease, abrogates IgG-medi-
ated neuroprotection and related microglial enhanced recycling endocy-
tosis and TNF-α production. Furthermore, E-prostanoid receptor subtype
2 activation by prostaglandin E2, which is released by hippocampal
pyramidal neurons proportionate to their electrical activity, amplifies
IgG-mediated effects on microglia. This suggests paracrine mediators
released from neurons, due to their increased activity, can affect
microglial TNF-α release via amplification of recycling endocytosis. These
results confirm and extend evidence indicating that microglial pro-
inflammatory activation over time is nutritive. Furthermore, they begin to
illustrate specific immune signaling mechanisms by which neurons and
microglia interact to enhance brain function. 
Adaptive nature of activity-dependent neuroprotection
Neuroprotection from EE requires time to develop. This suggests that
EE, like other preconditioning stimuli (Barone et al. 1998; Nishio et al.
2000), requires new protein synthesis. The predominant effect of TNF-α
is to alter gene expression (Abbas and Lichtman 2003). Thus, TNF-α is
well positioned to orchestrate the activity-dependent structural and func-
TNF-α and microglial hormesis from brain activity
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Figure 7 legend, continued
Microglial recycling endocytosis (F) and TNF-α production (G) also respond to IgG in a physiologi-
cal hormetic dose-response pattern. (H) Finally, neuroprotection from IgG is amplified by co-incu-
bation of IgG with Butaprost, an EP2 receptor agonist, which acted as a surrogate of prostaglandin
E2 release from increased neuronal activity. This amplification was removed by abrogation of TNF-α
signaling via sTNFR1 inclusion (not shown). Results adapted with permission from Hulse et al. 2008. 
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tional adaptation necessary for EE-based neuroprotection. However, the
precise nature of these adaptive processes and their relation to TNF-α
and microglial activation remain undefined. Nonetheless, evidence from
R. P. Kraig and others
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FIGURE 8. Sufficient and phasic signaling of activity-dependent neuroprotection. (A) Brain vitality
and neural activity (i.e., the degree and duration of brain cellular depolarization) follow a hormetic
dose response relationship. At the extremes, severely reduced (e.g., coma) and excessive activity
(e.g., stroke) are lethal. On the other hand, increased brain cell activity from environmental enrich-
ment (EE) or long-term potentiation, a cellular model of learning, is maximally nutritive. Episodic
spreading depression, the underlying cause of migraine, can be neuroprotective. However, when
spreading depression becomes too frequent, episodic migraine may be transformed into chronic
migraine because periods for adaptive signaling are too short. (B) The principal tenets of physio-
logical conditioning hormesis are illustrated as the need for an initial irritative stimulus (1) which
over time results in a period of increased vitality via anabolic structural and functional changes (2).
Repetitive phasic episodes of initiating stimuli (3) further enhance brain vitality (4). However, when
the frequency of initiating stimuli precludes adequate periods of adaptation (5), maladaptive struc-
tural and functional changes ensue that include the development of disease (e.g., chronic migraine).
In the extreme (6), initiating stimuli are so overwhelming that associated irritative signals (i.e.,
microglial activation and production of TNF-α and oxidants) only enhance neurodegeneration. 
14
Dose-Response: An International Journal, Vol. 8 [2014], Iss. 4, Art. 3
https://scholarworks.umass.edu/dose_response/vol8/iss4/3
physical activity, dietary restriction, and ageing research provide provoca-
tive clues. 
Radak and colleagues (2008) review evidence that moderate physical
activity improves general health by triggering adaptive responses to reac-
tive oxygen species (ROS). They note that physical activity extremes (i.e.,
inactivity and excessive activity) lead to deterioration in health, consistent
with the basic tenet of hormesis. Exercise must be sufficiently high to ini-
tiate “stress” so that adaptive responses will occur. Importantly, exercise
needs to be intermittent with sufficient periods of rest to allow for the
development of adaptive responses associated with improved muscle
(and organismal) health. We suggest this requirement not only applies to
brain and EE (Figure 8), but may also be involved in the maladaptive
effects of excessively increased brain activity (see below). The authors
point to literature (Gomez-Cabrera et al. 2005) indicating that ROS inhi-
bition via exogenous scavengers abrogates the positive effects of physical
exercise, a result now extended to humans (Ristow et al. 2009). 
Dietary restriction may also improve organismal health. Schulz and
coworkers (2007) show that glucose restriction increases the lifespan of
Caenorhabditis elegans. This caloric restriction paradigm triggers increased
ROS formation, and importantly, increased ROS scavenging via height-
ened catalase activity. Similar to physical activity, exogenous antioxidants
and vitamins that scavenge ROS may reduce the worm lifespan initially
increased by dietary restriction. 
The Mattson laboratory emphasizes that these peripheral precondi-
tioning strategies for exercise and dietary restriction hormesis involving
ROS are likely to apply to the ageing brain (Arumugam et al. 2006). This
suggestion is supported by data showing that NMDA receptor activation
enhances neuronal antioxidant defenses (Papadia et al. 2008).
Modestly increased ROS production and the pronounced impact of
intrinsic antioxidants on neurological preventative health may be linked to
upstream microglial activation that includes production of TNF-α and oxi-
dants. Several lines of evidence support this suggestion. First, TNF-α stimu-
lates glucose uptake into astrocytes (Yu et al. 1995; Véga et al. 2002), which
in turn provide high-energy substrates to neurons (Barros and Deitmer
2009). Second, learning increases brain oxidative metabolism (Heiss et al.
1992). Third, microglia are activated by synaptic activity (Ziv et al. 2006;
Hulse et al. 2008) and activated microglia release ROS (Block et al. 2007;
Innamorato et al. 2009), which can prompt increased generation of neural
tissue antioxidants. Fourth, oxidant stress plus antioxidant responses can
modulate synthesis of proteins involved in activity-dependent neuroprotec-
tion, most likely via the “translational switch,” eukaryotic translational initi-
ation factor 2α (Costa-Mattiolo et al. 2009; Tan et al. 2009). 
Fifth, Radak and colleagues (2008) emphasize that not only must
exercise be sufficiently stressful, but adequate rest periods are also essen-
TNF-α and microglial hormesis from brain activity
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tial to improve health. While sufficiently increased brain activity (i.e., EE)
is necessary to initiate improved health, sleep may provide the essential
rest period required for adaptive changes. Vyazovskiy and colleagues
(2008) note that while the wake state is associated with potentiation of
synaptic function, sleep reverses this to depotentiation. This scenario is
schematized in Figure 8. Importantly, although synaptic potentiation falls
with sleep, protein synthesis rises (Ramm and Smith, 1990). Seemingly
paradoxical to our overall thesis involving neural activity and TNF-α, hip-
pocampal TNF-α mRNA rises with sleep (Cearley et al. 2003). However,
TNF-α changes associated with LTP in the wake state may be localized to
only the synaptic regions activated by learning and thus changes would
not be detectable in whole brain regions used for the circadian mRNA
measurements. Finally, brain catalase activity (and possibly the activities
of other antioxidants which collectively can influence protein synthesis),
shows phasic behavior (Sani et al. 2006). 
In summary, mounting evidence indicates that physiologically
increased neural activity begets increased neuronal excitability via mech-
anisms that include TNF-α from microglia (Figure 9). When this
increased neural activity is sufficiently phasic, brain becomes more
resilient. In contrast, heightened neural activity and associated glial acti-
vation, without adequate periods for adaptation, may leave brain more
susceptible to disease (see below). 
MALADAPTIVE POTENTIAL OF ENHANCED BRAIN ACTIVITY
Considerations of brain physiological conditioning hormesis have
largely focused on the nourishing and restorative capacities of this sig-
naling response pattern. However, examination of mechanisms by which
increased brain activity can become maladaptive may help explain select
brain diseases. For example, spreading depression is a non injurious and
transient perturbation of brain that, like EE, triggers microglial activation
(Caggiano and Kraig 1996), increased TNF-α (Kunkler et al. 2004)
(Figure 10), and neuroprotection that depends on TNF-α (Kraig et al.
2005). Spreading depression is also the most likely underlying cause for
episodic migraine aura and pain (Moskowitz et al. 1993; Kunkler and
Kraig 2003; Lauritzen and Kraig 2005). 
Reduced inhibitory synaptic function plays a key role in the mecha-
nisms of spreading depression. Our work, and that from the Somjen lab-
oratory (for review see Kunkler et al. 2005), show that a synchronous
reduction in synaptic inhibitory drive occurring over a sufficiently large
brain volume initiates spreading depression (Figure 10). In addition, as
spreading depression subsides, inhibitory synaptic function is last to
recover. We speculate that as spreading depression (i.e., migraine)
becomes more frequent, the lack of sufficient periods for compensatory
adaptive recovery leads to increased brain excitability from reduced inhi-
R. P. Kraig and others
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bition, which may account for the transformation of episodic to chronic
migraine (Figure 8). 
Chronic migraine is a prevalent healthcare burden (Lipton et al.
2004) whose pathogenesis remains incompletely defined. Evidence sug-
gests that chronic migraine occurs with central sensitization of sensory
pathways that involves increased expression of pro-inflammatory media-
tors and alterations in the periaqueductal gray (Aurora 2009). However,
increased migraine frequency also correlates with the transformation of
episodic migraine to chronic migraine (Silberstein and Olesen 2005),
suggesting the frequency of spreading depression may be an initiating
cause of chronic migraine pain. Accordingly, central sensitization of sen-
sory pathways and alterations of the periaqueductal gray may be “down-
TNF-α and microglial hormesis from brain activity
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FIGURE 9. Schematic of neuro-immune initiating signaling of activity-dependent neuroprotection.
(1) Physiologically enhanced neuronal activity, if sufficiently phasic, becomes neuroprotective. (2)
This nutritive process begins with activity-dependent release of neuronal paracrine mediators includ-
ing high energy phosphates, glutamate, potassium and especially prostaglandins, which can enhance
(3) recycling endocytosis associated with TNF-α production from microglia. Astrocytes are also like-
ly involved in activity-dependent release of paracrine mediators, which activate microglia. (4) As a
result, TNF-α released from microglia further triggers an increase in neuronal activity by (5) increas-
ing the surface expression of NMDA and AMPA receptors while decreasing expression of GABA
receptors. (6) At the same time, TNF-α from microglia likely influence astrocytes. The choreography
between this neuron-glial interactive behavior from heightened neuronal activity involves two impor-
tant tenets. First, it must be sufficiently robust to trigger “irritative” signaling that initiates subsequent
anabolic adaptive processes. Second, it must be sufficiently phasic to allow for homeostatic plastic
processes to return activity levels toward normal. Furthermore, but in contrast to a return toward nor-
mal, heightened physiological activity must be sufficiently phasic to allow anabolic processes suffi-
cient time to build a stronger resilience to neurological disease. While these latter “processes” remain
undefined, evidence from physical activity, dietary restriction, and ageing research suggest that
antioxidant defenses and anabolism in response to oxidant stress may be involved. 
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FIGURE 10. Spreading depression in hippocampus begins with a reversal of somatic pyramidal neu-
ron inhibition. (A) Like environmental enrichment (EE), spreading depression (SD) triggers a sig-
nificant (“*”, P<0.05, Student’s t test) rise in TNF-α expression from 171±31 pg/mg brain of sham
controls (n=5) to 340±23 pg/mg brain (n=9) six hrs after one hr of recurrent SD (Kunkler et al.
2004). This rise likely comes from microglia and is involved in SD-dependent neuroprotection (Kraig
et al. 2005). (B) Optical current source density analyses (Kunkler et al. 2005) begin to allude to mech-
anisms by which episodic migraine, which is neuroprotective, may become maladaptive and account
for chronic migraine. For example, estimation of current flow from principal neurons (i.e., pyrami-
dal neurons) shows that SD begins with a massive current sink (blue) at pyramidal neuron cell bod-
ies (i.e., inward current) and is surrounded by current sources (red; i.e., outward current flow) in the
adjacent dendrites. This is illustrated in the pseudo-colored left hand image where a thick black line
marks the dentate gyrus and a thin black line marks the pyramidal neuron area. This current flow
pattern is opposite to that seen after normal electrical activity, where the soma is a sink (see below)
and is further emphasized here by superimposition of the SD-initiating current flow pattern on rep-
resentative images of pyramidal axons (using neurofilament immunostaining (middle image)) and
pyramidal neuron dendrites (using cellular injections of Biocytin (right hand image)). Calibration
bar is 250 µm. (C) Under normal conditions, current flow in pyramidal neurons from evoked or
spontaneous activity shows the typical current sink-source-sink-source pattern moving from the distal
dendrites to cell body area (left, “1”). Then with increased activity due to an initiating stimulus, neu-
ronal activity increases (bursting; left, “2”) followed by the onset of SD, where currents at the soma
reverse (middle, “3”, “*”). This is followed by the massive interstitial DC potential change of SD (i.e.,
nearly complete cellular depolarization (right, “4”)), where the current flow pattern returns to a nor-
mal orientation but is markedly prolonged to seconds instead of the milliseconds seen with normal
activity. Calibration bars are 10 sec (horizontal) and 10 mV (vertical, negative downward). Perhaps,
Figure 10 legend continued on next page
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stream” signaling phenomena of chronic migraine while recurrent
spreading depression is the “upstream” neural signaling causal change. 
Spreading depression initiates pro-inflammatory changes. Astrocytes
(Kraig et al. 1991) and microglia (Caggiano and Kraig 1996) show reac-
tive changes for weeks after spreading depression. Importantly, spreading
depression also triggers increased TNF-α production (Kunkler et al.
2004) and microglial activation (Caggiano and Kraig 1996) which would
include increased production of tissue oxidants. Together these factors,
as well as release of other factors such as brain derived neurotrophic fac-
tor from microglia (Coull et al. 2005), can reduce neural network
inhibitory synaptic drive, which would promote recurrent spreading
depression (i.e., chronic migraine). Evidence supports this maladaptive
potential of physiological conditioning hormesis. Repetitive spreading
depression triggers a selective suppression of inhibitory function (Kruger
et al. 1996) and cortical hyperexcitability in migraineurs stems from
reduced inhibition (Palmer et al. 2000). Accordingly, microglial activation
from increased brain activity that occurs without sufficient time to permit
adequate adaptation, may initiate maladaptive consequences to brain. 
SUMMARY
Physiological conditioning hormesis characterizes the signaling
response patterns by which increased brain activity from EE generates
enhanced resilience to brain disease. Two basic tenets of hormesis
require that initiating irritative, but not injurious, stimuli are sufficiently
robust and that adequate periods of recovery from stressful initiating
stimuli occur to allow adequate time for adaptive processes to take effect.
Microglia, because of their activation from neural activity and their asso-
ciated production of TNF-α and oxidant irritants, are well-positioned to
orchestrate hormetic immune signaling that establishes the phenotype of
neurological health and disease from brain activity.
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Figure 10 legend, continued
when SD becomes too frequent, tonic somatic inhibition is enhanced by the lack of adaptation to ini-
tiating irritative stimuli from microglia that include TNF-α and oxidants, which can reduce or reverse
inhibitory synaptic drive. As a result, pyramidal neuron excitability is enhanced and brain becomes
more susceptible to SD, resulting in recurrent SD (i.e., chronic migraine). Optical current source
density images were adapted with permission from Kunkler et al. 2005.
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